Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Risk for Cardiovascular Disease (CVD)”

45 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 45 results

Not applicableNot Yet RecruitingNCT07104968
What this trial is testing

Mild and Moderate Aortic Regurgitation: Risk Factors for Progress and Outcome

Who this might be right for
Aortic Regurgitation
Uppsala University 35,000
Not applicableStudy completedNCT00296023
What this trial is testing

Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
University of California, San Francisco 25
Testing effectiveness (Phase 2)WithdrawnNCT04531579
What this trial is testing

Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Trauma Patients

Who this might be right for
Acute Kidney InjuryIschemia Reperfusion Injury
Westat
Not applicableStudy completedNCT01233921
What this trial is testing

Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+86 more
Martin, Paul 6
Testing effectiveness (Phase 2)Ended earlyNCT04530617
What this trial is testing

Camostat and Artemisia Annua vs Placebo in COVID-19 Outpatients

Who this might be right for
Covid19DiabetesHypertension+1 more
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 246
Large-scale testing (Phase 3)UnknownNCT00445497
What this trial is testing

Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia

Who this might be right for
Brain and Central Nervous System TumorsLymphomaNeutropenia+3 more
Clatterbridge Centre for Oncology 400
Early research (Phase 1)Active Not RecruitingNCT01815749
What this trial is testing

Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisCutaneous B-cell Non-Hodgkin LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+21 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT00616980
What this trial is testing

Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia

Who this might be right for
Peripheral Artery DiseasePeripheral Vascular DiseaseCritical Limb Ischemia
Losordo, Douglas, M.D. 28
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Not applicableLooking for participantsNCT06953232
What this trial is testing

Acute Impact of Whey Protein-enriched Milk Fat Globule Membrane Supplementation on Postprandial Markers of Heart and Brain Health

Who this might be right for
Cardiovascular DiseasesCognitionOverweight or Obesity+2 more
Loughborough University 16
Not applicableLooking for participantsNCT04888247
What this trial is testing

HighFLO Study - HighLife Trans-septal Mitral Valve Replacement (TSMVR) Feasibility Study of the Open Cell CLARITY Valve

Who this might be right for
Mitral Regurgitation
HighLife SAS 30
Not applicableWithdrawnNCT03213574
What this trial is testing

Impact of GDT in Robot-assisted Laparoscopic Urological Surgery for Low to Moderate Risk Patients

Who this might be right for
Vascular HypotensionHypovolemiaHypervolemia
Loma Linda University
Testing effectiveness (Phase 2)UnknownNCT01219725
What this trial is testing

Cardiovascular Prophylaxis for Postmenopausal Women

Who this might be right for
Cardiovascular Disease
University of Leeds 100
Not applicableStudy completedNCT01176084
What this trial is testing

Low Carb Diets & Exercise for Cardiovascular Disease (CVD) Reduction

Who this might be right for
Obesity
University of Surrey 56
Testing effectiveness (Phase 2)Study completedNCT00049504
What this trial is testing

Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+94 more
Fred Hutchinson Cancer Center 53
Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Not applicableStudy completedNCT00689377
What this trial is testing

Prevalence of Peripheral Arterial Disease in Subject With a Moderate Risk of Cardiovascular (CV) Disease (CVD) in Primary Prevention

Who this might be right for
Peripheral Arterial Disease (PAD)Moderate Risk for Cardiovascular Disease (CVD)
AstraZeneca 9,000
Testing effectiveness (Phase 2)Study completedNCT00003658
What this trial is testing

Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Other B-cell Cancers

Who this might be right for
LeukemiaLymphoma
Memorial Sloan Kettering Cancer Center 60
Early research (Phase 1)Study completedNCT00004904
What this trial is testing

Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
Northwestern University
Not applicableStudy completedNCT05214573
What this trial is testing

Second-line Therapies for Patients With Type 2 Diabetes and Moderate Cardiovascular Disease Risk

Who this might be right for
Type 2 DiabetesCardiac Disease
Mayo Clinic 386,301
Next Page
30